Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., Baiyunshan Pharmaceutical General Factory

Chine

Commandez votre montre hebdomadaire Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., Baiyunshan Pharmaceutical General Factory
Quantité totale PI 12
Rang # Quantité totale PI 130 451
Note d'activité PI 2,1/5.0    15
Rang # Activité PI 56 662

Brevets

Marques

6 0
0 0
6 0
0
 
Dernier brevet 2025 - Fabi enzyme inhibitor and use th...
Premier brevet 2020 - Pyrazolopyridine compound as ret...

Derniers inventions, produits et services

2024 Invention Fabi enzyme inhibitor and use thereof. The present application discloses a FabI enzyme inhibitor ...
2022 Invention Novel non-fluorinated quinolone compound and use thereof. Disclosed are a non-fluorinated quinol...
Invention Novel non-fluorinated quinolone compound and application thereof. Disclosed are a non-fluorinated...
Invention Piperazine derivatives and application thereof. A class of piperazine derivatives and applicatio...
Invention Piperazine derivatives and application thereof. A class of piperazine derivatives and an applicat...
2021 Invention Application of composition in preparation of drug for preventing and treating stroke. An applicat...
Invention Tumor chemotherapy pharmaceutical composition. Disclosed is a tumor chemotherapy pharmaceutical c...
Invention Crystal forms of pyridopyrazole compounds and preparation method therefor. Provided are crystal ...
Invention Quinoline compounds. Disclosed are a class of compounds represented by formula (II), and isomers...
Invention Quinoline compounds. Disclosed are a class of compounds represented by formula (II), and isomers ...
2020 Invention Pyrazolopyridine compound as ret inhibitor and application thereof. Disclosed is a series of pyra...
Invention Nitrogen-containing spiro derivative as ret inhibitor. Disclosed are a series of compounds with a...